Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Functional Neurosurgery
Sacral nerve stimulation (sns)
What sacral nerve stimulation (SNS) is, how sacral neuromodulation delivers gentle electrical pulses to the S3 nerve for bladder and bowel control, the two-stage trial and permanent implant, clinical evidence and success rates, approximate costs in Turkey compared with the UK, US and Germany, alternatives such as Botox, recovery milestones, potential risks and how to choose an experienced neurosurgical or urological hospital.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Functional Neurosurgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Sacral Nerve Stimulation (SNS)
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
What is sacral nerve stimulation (sns) and how does it work?
Sacral nerve stimulation (sns), frequently referred to as sacral neuromodulation (SNM), is an established surgical treatment designed to restore bladder and bowel control when conservative therapies have failed. The therapy functions by delivering gentle, controlled electrical pulses to the sacral nerves—specifically the third sacral spinal nerve (S3)—which emerge from the lower spine. These nerves coordinate the communication network between the spinal cord, pelvic floor muscles, urinary bladder, and bowel sphincters. When signalling becomes disordered, patients can experience disabling urinary urgency, involuntary leakage, inability to empty the bladder, or chronic bowel incontinence.
The treatment is carried out in two distinct stages: an initial evaluation trial using an external stimulator, followed by the subcutaneous implantation of a small, permanent pulse generator in the upper buttock if symptoms improve substantially. In Turkey, accredited hospitals offer sacral neuromodulation as part of advanced neuro-urological and colorectal care. For a broader overview of advanced neurological and spinal procedures, explore our guide to neurosurgery treatments in Turkey (hub).
Does sacral nerve stimulation (sns) work? Evidence and clinical results
Clinical evidence collected over more than two decades shows that sacral neuromodulation is effective for carefully selected patients with refractory pelvic organ dysfunction. Clinical guidance from bodies such as the UK National Institute for Health and Care Excellence (NICE) and the American Urological Association (AUA) supports sacral neuromodulation for urge urinary incontinence, urgency-frequency syndrome, non-obstructive urinary retention, and chronic faecal incontinence after pelvic floor physiotherapy and medications have proven inadequate.
In clinical trials and observational registry data, approximately 60% to 80% of individuals who undergo a successful evaluation phase and receive a permanent implant achieve at least a 50% reduction in daily leakage episodes or a 50% improvement in voiding frequency. Many individuals with non-obstructive urinary retention regain the ability to empty their bladder voluntarily, significantly reducing or eliminating the need for clean intermittent self-catheterisation. However, sacral neuromodulation is not a guaranteed cure, nor does it restore normal anatomy. Some patients experience diminishing symptom control over time or require parameter adjustments, lead repositioning, or battery replacements. Responsible surgical clinics assess every patient through a structured trial rather than promising total symptom elimination.
Who is a good candidate for sacral neuromodulation?
Determining candidacy involves an extensive assessment of lower urinary tract or colorectal function. Sacral neuromodulation is intended for people who have tried and exhausted first- and second-line treatments without sufficient relief or who experienced intolerable side effects from pharmaceutical regimens.
You may be a suitable candidate for a stimulation trial if you experience:
- Refractory overactive bladder presenting with severe urgency incontinence or debilitating urgency-frequency.
- Non-obstructive urinary retention, where the bladder muscle fails to contract adequately despite an unobstructed urinary outflow tract.
- Chronic faecal incontinence (accidental bowel leakage) caused by sphincter weakness, nerve dysfunction, or idiopathic pelvic floor discoordination.
- Failure to achieve control through behavioural changes, pelvic floor exercises, biofeedback, and oral drugs.
Conversely, sacral neuromodulation is not suitable for individuals with stress urinary incontinence (leakage caused by coughing, sneezing, or physical exertion), mechanical bladder outlet obstruction (such as severe urethral stricture or severe prostatic enlargement), complete anatomical spinal cord transection, active pelvic infections, or those unable to manage the patient programmer device. Pregnancy is also an absolute contraindication for active stimulation.
The two-stage procedure: how the trial and permanent implant work
The two-stage design is one of the most reassuring features of sacral neuromodulation, because it allows you to test whether nerve stimulation relieves your specific symptoms before committing to a permanent device.
Stage 1: The evaluation trial
The trial phase is typically performed under local anaesthesia with mild intravenous sedation in a hospital operating theatre equipped with fluoroscopy (live X-ray guidance). The surgeon inserts a fine, flexible tined lead through a tiny puncture in the lower back, positioning the four electrical contacts alongside the S3 sacral nerve root. Mild electrical test signals are applied to verify motor responses (such as a characteristic downward flexion of the great toe and contraction of the pelvic floor) and sensory responses (a gentle fluttering or vibration in the pelvic area). The lead is secured and connected to an external neurostimulator worn on a waistband. You return to your accommodation and record bladder or bowel activity in a daily diary for 4 to 14 days. If symptom frequency or incontinence episodes drop by 50% or more, the trial is judged successful.
Stage 2: Permanent neurostimulator implantation
During the second stage, also completed under local anaesthesia or light sedation, the surgeon creates a small subcutaneous pocket just below the waistline in the upper outer buttock. The existing permanent lead (or a newly placed definitive lead) is connected to a compact, hermetically sealed implantable pulse generator (IPG). The generator is tucked into the tissue pocket, and the small incisions are closed with dissolving sutures. The procedure generally lasts between 30 and 60 minutes.
Sacral nerve stimulation (sns) cost in Turkey compared with the UK, US and Germany
Because sacral neuromodulation involves sophisticated implantable biomedical hardware, total costs reflect both surgical hospital fees and device acquisition. The table below presents approximate cost ranges for complete two-stage evaluation and permanent implantation across different countries. These figures are illustrative ranges rather than specific hospital quotes.
| Country | Approximate cost range |
|---|---|
| Turkey | €9,000 – €17,500 |
| United Kingdom | €16,000 – €28,000 |
| United States | €25,000 – €45,000 |
| Germany | €18,000 – €30,000 |
Several factors account for variation in the sacral nerve stimulation (sns) price. The primary driver is device selection: modern ultra-compact rechargeable stimulators cost more upfront but last 15 years or more, whereas non-rechargeable devices carry a lower initial purchase price but require surgical battery replacement after 4 to 6 years. Package pricing in Turkey commonly includes pre-operative diagnostic evaluations, both procedural stages (or a single consolidated hospital pathway), device programming equipment, hospital accommodation, nursing care, medication, and airport transfers. You can request an itemised treatment plan and price breakdown through our free quote form.
Sacral nerve stimulation compared with Botox and tibial nerve stimulation (PTNS)
Patients evaluating sacral neuromodulation frequently weigh it against other interventional treatments for refractory pelvic floor symptoms. Similar to how vagus nerve stimulation is utilised within the surgical treatment of epilepsy, sacral neuromodulation relies on programmed electrical impulses to regulate abnormal neural pathways. The table below outlines how sacral neuromodulation compares with intravesical botulinum toxin (Botox) injections and percutaneous tibial nerve stimulation (PTNS).
| Treatment method | Best suited to | Typical limits |
|---|---|---|
| Sacral nerve stimulation (SNS) | Refractory overactive bladder, non-obstructive retention, faecal incontinence | Surgical implant; requires trial phase; periodic battery or device replacement |
| Intravesical Botox injections | Overactive bladder with urge incontinence unresponsive to oral medications | Temporary effect (6–9 months); repeated cystoscopic injections; risk of urinary retention |
| Percutaneous tibial nerve stimulation (PTNS) | Patients seeking non-surgical neuromodulation for urgency and frequency | Requires weekly clinic visits for 12 weeks; ongoing maintenance sessions; modest efficacy in retention |
Botox provides targeted relaxation of the bladder wall but must be repeated once or twice a year and carries a risk of temporary urinary retention requiring self-catheterisation. PTNS stimulates the posterior tibial nerve near the ankle to indirectly modulate sacral pathways; while completely non-surgical, it requires prolonged clinic visits and does not treat non-obstructive urinary retention. Sacral neuromodulation offers a continuous, adjustable therapy that addresses both urinary and faecal symptoms simultaneously.
Sacral nerve stimulation (sns) before and after: what symptom relief looks like
Understanding what sacral nerve stimulation (sns) before and after results entail helps establish grounded expectations. Clinical improvement is measured objectively through voiding and bowel symptom diaries rather than visual physical changes.
Prior to treatment, patients often experience 12 to 20 bathroom visits each day, frequent night-time awakenings (nocturia), sudden uncontrollable urges, significant pad usage, or chronic dependence on catheterisation tubes. Following successful neuromodulation, patients typically record a marked reduction in daily urinary frequency (down to 6 to 8 voids), fewer or zero nocturnal awakenings, and a significant drop in incontinence accidents. Those with faecal incontinence frequently regain sufficient bowel warning time to reach a toilet comfortably, allowing them to resume social outings, work, and physical activities without anxiety.
However, the device does not make the bladder or bowel immune to normal physiological variations, dietary irritants (such as caffeine or alcohol), or urinary tract infections. Sensation from the stimulator is described as a mild, gentle tapping or fluttering sensation in the perineum or lower pelvis; it should never cause pain. You will be taught how to adjust the stimulation amplitude or change programs using a handheld remote control.
Your trip to Turkey and sacral nerve stimulation (sns) recovery timeline
Undergoing sacral nerve stimulation (sns) in Turkey requires careful travel planning around the two treatment stages. International patients can choose either a single extended visit of 8 to 12 days—covering initial consultation, Stage 1 lead placement, a multi-day trial evaluation, and immediate Stage 2 implantation if successful—or two shorter visits separated by several weeks. To understand each stage of travel, treatment scheduling, and hospital coordination, read through how it works.
The physical recovery timeline proceeds in predictable stages:
- Days 1–3: Mild bruising and localised tenderness around the buttock incision and lead exit site. Simple oral painkillers manage discomfort. You can walk gently from the first day. Showering requires keeping the trial dressing completely dry during Stage 1.
- Weeks 1–2: Following permanent Stage 2 placement, wound edges seal. Desk-based work and light daily routines can usually resume after 7 to 10 days. The surgical team checks the incisions before clearing you to fly home.
- Weeks 3–6: It takes roughly 4 to 6 weeks for fibrous tissue to secure the lead firmly in place around the sacral bone. During this window, you must strictly avoid heavy lifting (over 5 kg), vigorous bending, twisting at the waist, strenuous exercise, and swimming.
- Beyond 6 weeks: Full return to normal exercise, sexual activity, and daily hobbies. Ongoing follow-up takes place via secure telemedicine check-ins to monitor symptom diaries and device settings.
Risks, complications and long-term device management
Sacral neuromodulation has a well-documented safety profile confirmed by international health bodies such as the UK National Health Service (NHS), NICE, and the US Food and Drug Administration (FDA). Because the therapy is minimally invasive and completely reversible—the lead and stimulator can be removed at any time—permanent nerve injury is extremely rare.
Recognised surgical and technical risks include:
- Lead displacement or migration: The flexible lead can shift position, particularly during the first few weeks before tissue healing occurs, resulting in loss of therapeutic stimulation. This may necessitate a minor revision procedure.
- Infection or seroma: Local infection at the buttock incision or pocket site occurs in a small percentage of cases and may require antibiotics or temporary device removal.
- Implant site pain or discomfort: Some patients feel discomfort where the generator sits in the upper buttock, especially when leaning back against firm chairs or sleeping on that side.
- Undesirable stimulation: A sudden jolt or unpleasant buzzing sensation can happen if settings are too high or if the body changes posture abruptly. This is easily corrected by dialling down the voltage via the handheld programmer.
- Battery depletion and revision: Non-rechargeable units require replacement under local anaesthesia after several years. Modern rechargeable systems require regular charging sessions at home via a wearable charging belt.
Most contemporary neurostimulation systems are approved for full-body magnetic resonance imaging (MRI) under specific scanning conditions; your surgical team will provide an official medical implant card detailing your device model and MRI safety parameters.
How to choose an experienced neuromodulation team and questions to ask
Sacral neuromodulation requires meticulous surgical precision and comprehensive aftercare programming. When evaluating clinics for sacral nerve stimulation (sns) Turkey, look for hospitals staffed by certified functional urologists, colorectal surgeons, or neurosurgeons with documented subspecialty fellowships in neuromodulation and pelvic floor reconstruction. Specialised neuromodulation units frequently operate within comprehensive neurological departments; see our overview of neurosurgery treatments in Turkey. Before committing to overseas treatment, review our step-by-step breakdown on how it works.
Be alert to red flags: clinics that offer to skip the Stage 1 trial phase and implant a permanent generator on day one, providers that claim guaranteed cure rates, facilities that do not possess a dedicated fluoroscopy suite, and services that cannot arrange long-term telemedicine programming support once you return home.
Key questions to ask during your consultation:
- How many sacral neuromodulation procedures does the lead surgeon perform each year?
- Which device manufacturer and model do you recommend for my situation, and is it a rechargeable or non-rechargeable system?
- Is the proposed implant system conditionally safe for full-body MRI scans?
- What exact criteria do you use to evaluate success during the Stage 1 trial?
- How does the clinical team handle device reprogramming or technical troubleshooting after I fly back to my home country?
- What are the hospital protocols if an incision complication or lead migration occurs while I am in Turkey?
To receive an initial assessment based on your medical history and bladder diary, submit your details for a free quote.
Hospitals with Neurosurgery in Turkey
Frequently asked questions
Sacral nerve stimulation (SNS), or sacral neuromodulation, is a minimally invasive surgical therapy that delivers gentle electrical pulses to the S3 sacral nerve. This modulates communication between the spinal cord, bladder, bowel, and pelvic floor. It is primarily used for severe overactive bladder, non-obstructive urinary retention, and chronic faecal incontinence after medications and conservative therapies have failed.
Yes, clinical trials and national health registry data demonstrate that 60% to 80% of patients who undergo a successful temporary trial and receive a permanent implant achieve at least a 50% reduction in symptoms. Many patients regain voluntary bladder emptying or eliminate accidental bowel leakage. It is not an anatomical cure, but it provides significant, sustained symptom control for refractory dysfunction.
In Turkey, the approximate cost for complete sacral neuromodulation typically ranges between €9,000 and €17,500, compared with €16,000 to €28,000 in the UK and upwards of €25,000 in the US. The price depends on whether a rechargeable or non-rechargeable neurostimulator is chosen, hospital stay duration, and package inclusions. Each hospital confirms an itemised quote following case review.
Results are evaluated through functional symptom diaries rather than visual physical changes. Before surgery, patients often endure frequent daytime and night-time bathroom trips, severe urgency, accidental leakage, or reliance on self-catheterisation. Afterwards, successful treatment typically reduces daily voids to normal intervals (6 to 8 times daily), dramatically decreases involuntary accidents, and allows patients to resume social activities without constant restroom anxiety.
Initial recovery from the small incisions takes about one to two weeks, after which most patients can return to desk work. However, you must avoid heavy lifting over 5 kg, bending, twisting, and strenuous exercise for four to six weeks. This precaution allows internal scar tissue to form around the tined lead, preventing lead migration before it is securely anchored.
The surgical stages are performed under local anaesthesia with sedation, meaning you feel no pain during lead or generator placement. Afterwards, mild local tenderness and bruising are common and managed with standard pain relievers. The ongoing stimulation itself feels like a mild, fluttering or gentle tapping sensation in the pelvic floor; it should never feel sharp or painful.
The longevity depends on the type of pulse generator implanted. Modern rechargeable neurostimulators are designed to last 15 years or more with periodic home charging. Non-rechargeable devices typically last between four and six years depending on electrical settings, after which the pocket is reopened under local anaesthesia to replace the battery unit while leaving the original lead in place.
Yes, sacral neuromodulation is approved by the FDA, NICE, and European regulatory bodies with a strong long-term safety profile. Because it is completely reversible, the system can be turned off or surgically removed without permanent nerve damage. Recognised risks include lead migration, pocket infection, localised discomfort, or changes in stimulation sensation, which are typically manageable through programming or minor revision.
While intravesical Botox injections temporarily paralyse bladder wall muscles, they require repeated cystoscopies every 6 to 9 months and carry a risk of requiring temporary self-catheterisation. Sacral neuromodulation offers continuous, reversible therapy via an implanted device, treats both urinary retention and bowel incontinence, and allows patient-controlled amplitude adjustment without repeated injections into the bladder wall.
If completing the trial and permanent implant in a single consolidated trip, plan to stay in Turkey for approximately 8 to 12 days. This provides adequate time for pre-operative consultations, Stage 1 lead placement, a multi-day symptom evaluation trial, permanent Stage 2 implantation, and wound healing verification before your flight home.
Patient stories